UTI Healthcare Fund - G

NAV ₹156.909 ↓ -1.54 (-0.97 %) as on 14 May 21

(Erstwhile UTI Pharma & Healthcare Fund)

Table of Contents

Scheme Objective
NAV Price Chart
Returns
- Historical Returns
- Compounded Returns
Growth Of 10k Over Years
Holdings / Portfolio
All Plan & Options
Fund Manager Information
Custodians
Registrar & Transfer Agent (RTA)
Administrator Companies
Auditors

Scheme Objective

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund launched on 28 Jun 99. It is a fund with High risk and has given a CAGR return of 14.9% since its launch. Ranked 40 in Sectoral category. Return for 2020 was 67.4% , 2019 was 1.2% and 2018 was -7.5% .

Below is the key information for UTI Healthcare Fund

NAV as on 14 May 21	₹156.909 ↓ -1.54 (-0.97 %)
Net Assets (AUM) as on 31 Mar 2021	₹618 Cr.
Launch Date	28 Jun 1999
Category	Equity - Sectoral
Rating	☆
Type	Open Ended Fund
Risk	High
AMC	UTI Asset Management Company Ltd

Alpha Ratio	0.88
Expense Ratio	2.59 %
Sharpe Ratio	2.061
Information Ratio	0.18
Benchmark	Not Available
Min Investment	₹5,000
Min SIP Investment	₹500
Exit Load	0-1 Years (1%),1 Years and above(NIL)

NAV Price Chart

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 14 May 21

Duration	Returns
1 Month	8.5%
3 Month	11%
6 Month	20.8%
1 Year	58.1%
3 Year	24%
5 Year	12.3%
10 Year
15 Year
Since launch	14.9%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

Year	Returns
2020	67.4%
2019	1.2%
2018	-7.5%
2017	6.2%
2016	-9.7%
2015	12.4%
2014	43.7%
2013	23.3%
2012	24.8%

Growth of 10k Over Years

Date	Value
30 Apr 16	₹10,000
30 Apr 17	₹9,832
30 Apr 18	₹9,827
30 Apr 19	₹9,784
30 Apr 20	₹11,306
30 Apr 21	₹17,201

Asset Allocation

Asset Class	Value
Cash	1.63%
Equity	98.37%

Sector Allocation

Sector	Value
Health Care	95.35%
Basic Materials	3.03%

Top Securities Holdings / Portfolio

Holdings/Securities

Name	Global Industry	Holding	Value	Quantity
Aurobindo Pharma Ltd (Healthcare) Equity, Since 31 Oct 13 \| AUROPHARMA	Drug Manufacturers - Specialty & Generic	10%	₹59 Cr	669,805 ↑ 13,783
Sun Pharmaceuticals Industries Ltd (Healthcare) Equity, Since 31 Oct 06 \| SUNPHARMA	Drug Manufacturers - Specialty & Generic	10%	₹59 Cr	982,457
Cipla Ltd (Healthcare) Equity, Since 31 Jan 03 \| 500087	Drug Manufacturers - General	9%	₹59 Cr	720,104
Dr Reddy's Laboratories Ltd (Healthcare) Equity, Since 28 Feb 18 \| 500124	Drug Manufacturers - Specialty & Generic	8%	₹52 Cr	115,140 ↑ 11,782
Divi's Laboratories Ltd (Healthcare) Equity, Since 30 Sep 17 \| DIVISLAB	Drug Manufacturers - Specialty & Generic	6%	₹39 Cr	106,427
Eris Lifesciences Ltd Registered Shs (Healthcare) Equity, Since 31 Mar 19 \| 540596	Drug Manufacturers - Specialty & Generic	6%	₹35 Cr	578,554
Cadila Healthcare Ltd (Healthcare) Equity, Since 31 Jan 03 \| 532321	Drug Manufacturers - Specialty & Generic	5%	₹33 Cr	754,423 ↑ 62,731
Fortis Healthcare Ltd (Healthcare) Equity, Since 31 Dec 20 \| 532843	Medical Care Facilities	4%	₹27 Cr	1,367,122
Ajanta Pharma Ltd (Healthcare) Equity, Since 31 Jul 17 \| 532331	Drug Manufacturers - Specialty & Generic	4%	₹25 Cr	141,398
J.B. Chemicals & Pharmaceuticals Ltd (Healthcare) Equity, Since 31 Dec 20 \| 506943	Drug Manufacturers - Specialty & Generic	4%	₹22 Cr	176,777 ↑ 33,179

1 - 10 of 28

Ready to Invest?
Talk to our investment specialist

Fund Managers

Name	Since	Tenure
V Srivatsa	3 Mar 17	4.16 Yr.

Custodians

Company	Address
Bank of Nova Scotia	12/13, Maker Chamber VI,220, Nariman Point
Citibank N.A. India	Trent House, 3rd Floor, G Block,,Plot No.60, Next to Citibank,,Bandra Kurla Complex,,Bandra (East),
Stock Holding Corporation of India	Mittal Court, ‘B’ Wing,,Nariman Point

Registrar & Transfer Agent

KFin Technologies Private Limited
Address	"KARVY HOUSE",46, Avenue 4, Street No.1,,Banjara Hills,
FAX	91-40-23311968
Email	mailmanager@karvy.com

Administrator Companies

Company	Address
UTI Mutual Fund	UTI Tower , `GN' Block,,Bandra Kurla Complex,,Bandra (E)

Auditors

Company	Address
Haribhakti & Co. Chartered Accountants	42, Free Press House,4th Floor,,215, Nariman Point,

All Plan & Options

Fund and Plan	NAV	6 Month	1 Year	3 Year	5 Year
UTI Healthcare Fund Growth	₹156.909 ↓ -1.54	20.84 %	58.12 %	24.01 %	12.34 %
UTI Healthcare Fund Normal Dividend, Payout	₹121.269 ↓ -1.19	20.84 %	58.12 %	24.01 %	12.34 %
UTI Healthcare Fund Normal Dividend, Reinvestment	₹121.269 ↓ -1.19	20.84 %	58.12 %	24.01 %	12.34 %
Data as on 14 May 21

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.

Shepard Technologies Pvt. Ltd : A -204, Technocity, Plot No X-4/1 & X-4/2, TTC, MIDC, Mahape, Navi Mumbai - 400710

AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153

Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing. Past performance is not indicative of future returns. Please consider your specific investment requirements before choosing a fund, or designing a portfolio that suits your needs.

Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.